UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 — Santa Monica, California

UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 is a clinical research site located in Santa Monica, California, United States 90404.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042?

UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 conducted?

UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 has 1 clinical trials on record. Their work covers Solid Tumor.

Is UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 accredited by Crixeo Health?

UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology, 2020 Santa Monica Boulevard, Suite 600 - Site 042?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.